You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2026

cyanocobalamin; tannic acid; zinc acetate - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cyanocobalamin; tannic acid; zinc acetate and what is the scope of patent protection?

Cyanocobalamin; tannic acid; zinc acetate is the generic ingredient in one branded drug marketed by Armour Pharm and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for cyanocobalamin; tannic acid; zinc acetate
US Patents:0
Tradenames:1
Applicants:1
NDAs:1

US Patents and Regulatory Information for cyanocobalamin; tannic acid; zinc acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Armour Pharm DEPINAR cyanocobalamin; tannic acid; zinc acetate INJECTABLE;INJECTION 011208-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Investment Scenario and Fundamentals Analysis for Cyanocobalamin, Tannic Acid, Zinc Acetate

Last updated: February 26, 2026

What Are the Market Drivers for Cyanocobalamin?

Cyanocobalamin, a synthetic form of vitamin B12, is widely used in dietary supplements and medical treatments for B12 deficiency. The global vitamin B12 market was valued at approximately $540 million in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 4.5% through 2028.[1]

Key Fundamentals

  • Demand Drivers: Increasing prevalence of pernicious anemia, neurological disorders related to B12 deficiency, and rising awareness of supplement health benefits.
  • Supply Dynamics: Cyanocobalamin is primarily produced via bacterial fermentation, with major suppliers in China, India, and Europe.
  • Pricing Trends: Prices have been relatively stable; recent supply chain disruptions caused short-term fluctuations.
  • Regulatory Landscape: Recognized as safe by FDA and EMA, with minimal barriers for market entry for established manufacturers.
  • Patent Landscape: No recent patents limit generic production, increasing competitive pressure but stabilizing the market for incumbents.

What Are the Investment Considerations for Tannic Acid?

Tannic acid, a polyphenol used in food, pharmaceuticals, and leather processing, has seen increased interest owing to its antioxidant properties. The global tannic acid market was valued at $380 million in 2021, with a forecast CAGR of 5.2% up to 2028.[2]

Key Fundamentals

  • Demand Drivers: Applications in pharmaceuticals (as astringent), food preservation, and natural dyes.
  • Raw Material Supply: Derived from plant sources like oak bark, gallnuts, and tea leaves; susceptible to agricultural variability.
  • Pricing Trends: Prices fluctuate based on raw material availability and environmental factors.
  • Regulatory Constraints: Approval processes vary; Generally Recognized As Safe (GRAS) status in the US facilitates market access.
  • Competitive Landscape: Fragmented market with small regional producers; opportunities exist for scale or branded product development.

What Are the Investment Insights for Zinc Acetate?

Zinc acetate, used as a dietary supplement, in topical dermatology, and as a chemical reagent, occupies a sizable niche in mineral supplements. The market was valued at $250 million in 2021, expected to grow at a CAGR of 4.8% through 2028.[3]

Key Fundamentals

  • Demand Drivers: Zinc deficiency prevalence, immune health focus, and COVID-19 related supplement use.
  • Supply Factors: Zinc ores are mined globally, with major production in China, Peru, and Australia; geopolitical events can influence supply stability.
  • Pricing Dynamics: Prices are influenced by zinc ore costs, environmental regulations, and global demand fluctuations.
  • Regulatory Environment: Food grade zinc acetate approved in multiple regions; no significant barriers for commercial distribution.
  • Market Competition: Dominated by few large chemical companies, with differentiation through purity and formulation capabilities.

Comparative Market Outlook

Ingredient Market Size (2021) CAGR (2022–2028) Key Demand Drivers Regulatory Status Supply Concentration
Cyanocobalamin $540 million 4.5% B12 deficiency, anemia Recognized safe Moderate (China, Europe)
Tannic Acid $380 million 5.2% Food, pharma, dyes GRAS status Fragmented, raw material dependent
Zinc Acetate $250 million 4.8% Zinc deficiency, immunity Widely approved Concentrated (China, Peru)

Risks and Opportunities

  • Market Risks: Price volatility due to raw material supply disruptions, regulatory changes, or new product innovations.
  • Intellectual Property: Limited patent protections, favoring generic and brand competition.
  • Supply Chain: Dependence on raw material sources for tannic acid and zinc, vulnerable to environmental and geopolitical factors.
  • Innovation Opportunities: Development of proprietary formulations, improved bioavailability, or sustainable sourcing.

Key Takeaways

  • The market for cyanocobalamin, tannic acid, and zinc acetate exhibits steady growth driven by health, nutritional, and industrial applications.
  • Supply chains are concentrated and susceptible to regional risks; diversification and strategic sourcing are vital.
  • Regulatory pathways are established; however, ongoing compliance remains necessary, especially for new formulations or indications.
  • Competitive landscape favors incumbents with scale, especially in zinc acetate and cyanocobalamin markets, due to their commoditized nature.
  • Innovation in delivery mechanisms or sustainable procurement can provide competitive advantages.

FAQs

1. Which ingredient has the highest growth potential?

Cyanocobalamin shows consistent demand driven by broad supplement use and medical indications, with a slightly higher CAGR compared to tannic acid and zinc acetate.

2. What are the main supply risks?

Supply disruption risks arise primarily for tannic acid, due to reliance on plant sources, and zinc acetate, because of geopolitical influence on zinc ore markets.

3. Are regulatory barriers significant?

Regulatory barriers are minimal for these ingredients in established markets. However, new formulations or claims may require additional approvals.

4. What are the main cost drivers?

Raw material prices, especially for tannic acid (agricultural variability) and zinc (ore costs), drive manufacturing costs. Regulatory compliance adds indirect costs.

5. How does environmental regulation impact supply?

Environmental regulations on mining and plant harvesting can restrict raw material availability, impacting supply stability and prices over the long term.


References

[1] MarketsandMarkets. (2022). Vitamin B12 Market by Source, Form, Application, and Region - Global Forecast to 2028.

[2] Research and Markets. (2021). Tannic Acid Market Report.

[3] Grand View Research. (2022). Zinc Acetate Market Size, Share & Trends.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.